Skip to content

Clinical trials

Phase 2 Brain Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Phase: Phase 2 Country / region: United Kingdom Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20051
20081
20112
20153
20162
20172
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting3
Active, not recruiting2
Terminated2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC4
University College, London4
Novartis Pharmaceuticals2
AbbVie1
Apollomics Inc.1
Celgene1
Hoffmann-La Roche1
Nationwide Children's Hospital1
Rigel Pharmaceuticals1
Seagen Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms18
Glioblastoma10
Glioma6
Central Nervous System Neoplasms5
Gliosarcoma5
Astrocytoma4
Breast Neoplasms3
Carcinoma, Non-Small-Cell Lung3
Oligodendroglioma3
Diffuse Intrinsic Pontine Glioma2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.